A dose mentioned in a paper is part of that study's intervention, not a recommendation for a different person, condition or product. For BPC-157, repeating a number without its clinical context can make an exploratory report sound like an established treatment standard.
A condition specific example
The interstitial cystitis pilot describes a small uncontrolled study involving a bladder-directed procedure and symptom assessment. It does not determine an injury-recovery regimen or show that a different route produces an equivalent result. This discussion is based on the accessible abstract, not a complete review of the procedure.
To infer a personal regimen from that report, one would have to assume that the condition, delivery, product characteristics and desired effect all transfer. Those assumptions are precisely what additional studies would need to test.
A studied exposure is not an optimum
A study may choose an exposure for feasibility or exploration without proving it is the most effective or safest. Establishing a useful regimen requires comparison of benefits and harms, a defined population and reliable measurement over an appropriate period.
The same reasoning applies to claims that body size alone solves the problem. Scaling a quantity does not create missing evidence about absorption, tissue exposure or clinical response. Nor does a calculator account for an uncertain product identity.
Regulatory wording needs a date
As checked on October 1, 2026, FDA's current safety-risk page lists BPC-157 under nominations withdrawn and retains safety concerns. That placement should not be rewritten as an old category label or interpreted as an approval.
A regulatory discussion and an individual clinical decision answer different questions. Neither a nomination nor an advisory meeting establishes a home-use regimen.
The useful next question for a clinician is what condition needs treatment and what supported options address it. This article provides no dose, conversion, cycle or administration instructions. A published experimental exposure cannot certify a catalog product or replace individualized medical assessment.